CELLMED (셀메드)

Cellmed Orthocellular Medicine and Pharmaceutical Association (셀메드 세포교정의약학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Study on an Osteoporosis Patient Using Ortho-Cellular Nutrition Therapy (OCNT)

세포교정영양요법(OCNT)을 이용한 골다공증 환자 사례 연구

  • Myung Jin Cha (Korea Workers' Compensation & Welfare Service Suncheon Hospital)
  • 차명진 (근로복지공단 순천병원)
  • Received : 2023.09.27
  • Accepted : 2023.09.27
  • Published : 2023.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: A case report on the improvement of symptoms in an osteoporosis patient using ortho-cellular nutrition therapy Methods: Currently a 70 years old Korean woman was diagnosed with osteoporosis in her late 50s around 2010 and continued to receive injection treatments once every three months. Her T-score did not improve, and fractures continued to occur in the ankles, wrists, shoulders, ribs, etc., even from light impacts. Results: The patient underwent an osteoporosis test in February 2019, which resulted in an average T-score of -2.5 or less, equivalent to being diagnosed with osteoporosis. OCNT has been performed since May 2019 (late 60s), and in the test received in April 2020, the T-score value improved to over -2.5 and was determined normal at the hospital. Since then, OCNT continued without any further injection treatments. Unlike before, even when she fell hard, she only suffered bruises without fractures, and no additional fractures have occurred. Conclusion: OCNT may help patients with similar problems relieve symptoms and recover.

Keywords

References

  1. Bartl R, Frisch B. Informed dicisions: osteoporosis. Heidelberg: Springer-Verlag Berlin; 2004. 253 p
  2. Ye-Soo Park, Diagnosis and treatment of osteoporosis, J Korean Med Assoc 2012 November; 55(11): 1083-1094 https://doi.org/10.5124/jkma.2012.55.11.1083
  3. Ji-Yoon Noh, Young Yang, Haiyoung Jung, Molecular Mechanisms and Emerging Therapeutics for Osteoporosis, Int J Mol Sci. 2020 Oct 15;21(20):7623
  4. Hyun Koo Yoon, Byung Seok Lee, Ki-Hyun Park, Joo Hyun Park, Kyung Ah Jeong. Osteoporosis in Korea, Clin Calcium. 2004 Sep;14(9):123-7.
  5. Shin CS, et al. Prevalence and risk factors of osteoporosis in Korea: a community-based cohort study with lumbar spine and hip bone mineral density. Bone 2010:47:378-387.
  6. Tara Coughlan and Frances Dockery.Osteoporosis and fracture risk in older people, Clinical Medicine 2014 Vol 14, No 2: 187-91 https://doi.org/10.7861/clinmedicine.14-2-187
  7. J M Lane, L Russell, S N Khan. Osteoporosis, Clin Orthop Relat Res. 2000 Mar;(372):139-50.
  8. N B Watts. Using bone mineral density T-scores to diagnose postmenopausal osteoporosis, Endocr Pract. 2000 MarApr;6(2):217-8 https://doi.org/10.4158/EP.6.2.217
  9. Korean Society for Bone and Mineral Resaerch. Physician's guide for diagnosis and treatment of osteoporosis 2015 [Internet]. Seoul: Korean Society for Bone and Mineral Research;2015 [cited 2019 Sep 5]. Available from: http://www.ksbmr.org/journal/index4.php
  10. Sungwook Chun, Pharmacological treatment of osteoporosis , J Korean Med Assoc 2019 October; 62(10):542-550 https://doi.org/10.5124/jkma.2019.62.10.542
  11. CALDER, Philip C. Immunomodulation by omega-3 fatty acids. Prostaglandins, leukotrienes and essential fatty acids, 2007, 77.5-6: 327-335. https://doi.org/10.1016/j.plefa.2007.10.015
  12. CHOI, So-Young, et al. Effects of Sigma Anti-bonding Molecule Calcium Carbonate on bone turnover and calcium balance in ovariectomized rats. Laboratory Animal Research, 27.4: 301-307(2011). https://doi.org/10.5625/lar.2011.27.4.301
  13. Ferencik, M., Ebringer, L. Modulatory effects of selenium and zinc on the immune system. Folia Microbiol 48, 417-426 (2003). https://doi.org/10.1007/BF02931378
  14. Schrauzer, G. Anticarcinogenic effects of selenium. CMLS, Cell. Mol. Life Sci. 57, 1864-1873 (2000). https://doi.org/10.1007/PL00000668
  15. CUNNINGHAM-RUNDLES, Susanna; MCNEELEY, David F.; MOON, Aeri. Mechanisms of nutrient modulation of the immune response. Journal of Allergy and Clinical immunology, 115.6: 1119-1128 (2005). https://doi.org/10.1016/j.jaci.2005.04.036
  16. Wang, H. et al. Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. 62, 294-296 (1999).
  17. Kamei, H. et al. Suppression of tumor cell growth by anthocyanins in vitro. 13, 590-594 (1995).
  18. Teresa Figueres Juher, Esther Bases Perez, An overview of the beneficial effects of hydrolysed collagen intake on joint and bone health and on skin ageing, Nutr Hosp. 2015 Jul 18;32 Suppl 1:62-6.
  19. Shan Shan Qi, et al. Chondroitin Sulfate Alleviates Diabetic Osteoporosis and Repairs Bone Microstructure via Anti-Oxidation, Anti-Inflammation, and Regulating Bone Metabolism, Front Endocrinol (Lausanne). 2021 Oct 27;12:759843
  20. Ezaki, J., Hashimoto, M., Hosokawa, Y. & Ishimi, Y. Assessment of safety and efficacy of methylsulfonylmethane on bone and knee joints in osteoarthritis animal model. J Bone Miner Metab 31, 16-25, (2013). https://doi.org/10.1007/s00774-012-0378-9
  21. Shujiro Otsuki, W. Q., Atsushi Ishihara, Toshiaki Kabe. Elucidation of dimethylsulfone metabolism in rat using a 35S radioisotope tracer method. Nutrition Research 22, 312-322 (2002).
  22. Hasegawa, T., Ueno, S., Kumamoto, S. & Yoshikai, Y. Suppressive effect of methylsulfonylmethane (MSM) on type II collagen-induced arthritis in DBA/1J mice. Japanese Pharmacology and Therapeutics 32, 421-427 (2004).
  23. BUTAWAN, Matthew; BENJAMIN, Rodney L.; BLOOMER, Richard J. Methylsulfonylmethane: applications and safety of a novel dietary supplement. Nutrients, 9.3: 290 (2017).
  24. Hanan Aljohani, et al. Methylsulfonylmethane Increases the Alveolar Bone Density of Mandibles in Aging Female Mice, Front Physiol. 2021 Oct 4;12:708905.